Halozyme Therapeutics
HALO
#1703
Rank
$12.46 B
Marketcap
$109.86
Share price
2.73%
Change (1 day)
53.24%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): $0.58 Billion USD

According to Halozyme Therapeutics's latest financial reports the company's current earnings are $1.66 Billion USD. In 2025 the company made an earning of $0.46 Billion USD a decrease over its 2024 earnings that were of $0.55 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $0.58 B24.95%
2025 $0.46 B-16.2%
2024 $0.55 B59.94%
2023 $0.34 B39.94%
2022 $0.24 B0.16%
2021 $0.24 B92.2%
2020 $0.12 B-278.96%
2019 -$72.26 Million-9.45%
2018 -$79.8 Million-229.51%
2017 $61.61 M-160.48%
2016 -$0.11 Billion216.03%
2015 -$32.24 Million-52.86%
2014 -$68.38 Million-18.09%
2013 -$83.48 Million55.88%
2012 -$53.56 Million169.94%
2011 -$19.84 Million-63.44%
2010 -$54.26 Million-7.19%
2009 -$58.46 Million15.91%
2008 -$50.44 Million83.89%
2007 -$27.43 Million78.1%
2006 -$15.41 Million16%
2005 -$13.28 Million45.24%
2004 -$9.15 Million682.42%
2003 -$1.17 Million1659.12%
2002 -$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$26.20 B 4,392.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$6.90 B 1,084.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$33.59 B 5,659.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$7.16 B 1,127.47%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-$0.49 Billion-182.80%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-$48.66 Million-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA